APA (7th ed.) Citation

H, G., JD, G., CE, G., X, W., M, L., MM, A., . . . CJ, B. (2026). Intralesional injection of CpG ODNs complexed with glatiramer acetate mitigates systemic cytokine toxicities and synergistically advances checkpoint blockade efficacy. Drug delivery and translational research, 16(6), 1736. https://doi.org/10.1007/s13346-025-01798-9

Chicago Style (17th ed.) Citation

H, Gong, Griffin JD, Groer CE, Wu X, Li M, Abdelaziz MM, Xu L, Forrest ML, and Berkland CJ. "Intralesional Injection of CpG ODNs Complexed with Glatiramer Acetate Mitigates Systemic Cytokine Toxicities and Synergistically Advances Checkpoint Blockade Efficacy." Drug Delivery and Translational Research 16, no. 6 (2026): 1736. https://doi.org/10.1007/s13346-025-01798-9.

MLA (9th ed.) Citation

H, Gong, et al. "Intralesional Injection of CpG ODNs Complexed with Glatiramer Acetate Mitigates Systemic Cytokine Toxicities and Synergistically Advances Checkpoint Blockade Efficacy." Drug Delivery and Translational Research, vol. 16, no. 6, 2026, p. 1736, https://doi.org/10.1007/s13346-025-01798-9.